<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JCN</journal-id>
<journal-id journal-id-type="hwp">spjcn</journal-id>
<journal-id journal-id-type="nlm-ta">J Child Neurol</journal-id>
<journal-title>Journal of Child Neurology</journal-title>
<issn pub-type="ppub">0883-0738</issn>
<issn pub-type="epub">1708-8283</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0883073811435918</article-id>
<article-id pub-id-type="publisher-id">10.1177_0883073811435918</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Brief Communication</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Zellweger Syndrome and Associated Brain Malformations</article-title>
<subtitle>Report of a Novel Peroxin1 (PEX1) Mutation in a Native American Infant</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Mohebbi</surname>
<given-names>Mohammad R.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0883073811435918">1</xref>
<xref ref-type="corresp" rid="corresp1-0883073811435918"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rush</surname>
<given-names>Eric T.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0883073811435918">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rizzo</surname>
<given-names>William B.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0883073811435918">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Banagale</surname>
<given-names>Raul C.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff3-0883073811435918">3</xref>
</contrib>
</contrib-group>
<aff id="aff1-0883073811435918">
<label>1</label>Siouxland Medical Education Foundation-University of Iowa, Sioux City, IA, USA</aff>
<aff id="aff2-0883073811435918">
<label>2</label>Munroe-Meyer Institute for Genetics and Rehabilitation, University of Nebraska Medical Center, Omaha, NE, USA</aff>
<aff id="aff3-0883073811435918">
<label>3</label>Neonatal Intensive Care Unit, St Luke’s Regional Medical Center, Sioux City, IA, USA</aff>
<author-notes>
<corresp id="corresp1-0883073811435918">Mohammad R. Mohebbi, MD, Siouxland Medical Education Foundation–University of Iowa, 2501 Pierce Street, Sioux City, IA 51104 Email: <email>mrmohebbi@yahoo.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>12</month>
<year>2012</year>
</pub-date>
<volume>27</volume>
<issue>12</issue>
<fpage>1589</fpage>
<lpage>1592</lpage>
<history>
<date date-type="received">
<day>19</day>
<month>11</month>
<year>2011</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>12</month>
<year>2011</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Zellweger syndrome (cerebrohepatorenal syndrome) is very rare and is the most severe form of peroxisomal biogenesis disorders. These can be caused by mutations in any of the currently known Peroxin genes and typically present in the neonatal period with multiorgan involvement. Patients usually do not survive beyond 1 year of age. This article reports a case of Zellweger syndrome in a male Native American infant confirmed by clinical findings, imaging studies, and biochemical analysis. Genetic studies show a novel mutation (c.3030G&gt;T, p. Glutamine1010Histidine) altering the last nucleotide of exon 19 in the Peroxin1 (PEX1) gene.</p>
</abstract>
<kwd-group>
<kwd>Zellweger syndrome</kwd>
<kwd>cerebrohepatorenal syndrome</kwd>
<kwd>peroxisome biogenesis disorder</kwd>
<kwd>polymicrogyria</kwd>
<kwd>Native American</kwd>
<kwd>PEX1</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Zellweger syndrome (cerebrohepatorenal syndrome) is a rare peroxisomal biogenesis disorder with estimated prevalence of 1:50 000.<sup><xref ref-type="bibr" rid="bibr1-0883073811435918">1</xref></sup> It typically presents in the neonatal period with multiorgan involvement.<sup><xref ref-type="bibr" rid="bibr2-0883073811435918">2</xref></sup> Patients exhibit hypotonia, facial dysmorphisms, dolichocephaly with large anterior fontanelle, psychomotor retardation, seizures, hepatomegaly, renal microcysts, and deafness. Patients with Zellweger syndrome usually do not survive beyond 1 year of age. Peroxisomal biogenesis disorders are caused by mutations in Peroxin genes, which encode peroxins involved in peroxisomal protein import and assembly. Peroxisomal biogenesis disorders have a wide clinical spectrum that ranges from the more severe Zellweger syndrome to the milder infantile Refsum disease.<sup><xref ref-type="bibr" rid="bibr3-0883073811435918">3</xref></sup>
</p>
<sec id="section1-0883073811435918">
<title>Case Report</title>
<p>This report involves a male infant who was delivered vaginally with a birth weight of 3587 g at 41 weeks gestation to a 24-year-old Native American gravida 2 para 1 female. Pregnancy was complicated with gestational diabetes, which was controlled by diet. A prenatal ultrasound showed agenesis of corpus callosum with ventriculomegaly. Delivery was significant for the presence of thick meconium-stained amniotic fluid and for infant respiratory distress, which required oxygen administration. The Apgar scores were 5 at 1 minute, 4 at 5 minutes, and 4 at 10 minutes. The infant was hypotonic, and dysmorphic features were noted including widely spaced eyes, flattened wide nasal bridge, high arched palate, widely spaced nipples, and talipes equinovarus. The parents were second cousins.</p>
<p>Further workup revealed markedly elevated aspartate aminotransferase and alanine aminotransferase. Urine organic acids showed elevated tyrosine metabolites. Plasma amino acids showed increased ornithine, threonine, and tyrosine, which was suggestive of hepatic dysfunction. Ferritin was elevated. Plasma very long chain fatty acids showed elevations of C26:0, C26:1, C24:0/C22:0, and C26:0/C22:0 ratio, which implies a defect in peroxisome biogenesis. Red blood cell plasmalogen levels were low, consistent with a defect in plasmalogen synthesis.</p>
<p>Magnetic resonance imaging (MRI) of the brain at 31 days of age showed diffuse areas of pachygyria and polymicrogyria and the appearance of subcortical laminar heterotopia in the perisylvian regions (<xref ref-type="fig" rid="fig1-0883073811435918">Figure 1</xref>), large bilateral areas of cortical dysplasia in the supratentorium, bilateral caudothalamic groove cyst (<xref ref-type="fig" rid="fig2-0883073811435918">Figure 2</xref>), microcephaly, and hypoplasia of the corpus callosum (<xref ref-type="fig" rid="fig2-0883073811435918">Figure 2</xref>). Electroencephalogram (EEG) showed intermittent rhythmic discharges in both hemispheres indicating an underlying multiple epileptic foci. Abdominal ultrasound showed mild bilateral renal cystic disease. Echocardiogram showed a small secundum atrial septal defect.</p>
<fig id="fig1-0883073811435918" position="float">
<label>Figure 1.</label>
<caption>
<p>T2 transverse magnetic resonance imaging (MRI) of the brain showing bilateral diffuse areas of polymicrogyria (white arrows) and subcortical laminar heterotopia (black arrows) in the perisylvian regions.</p>
</caption>
<graphic xlink:href="10.1177_0883073811435918-fig1.tif"/>
</fig>
<fig id="fig2-0883073811435918" position="float">
<label>Figure 2.</label>
<caption>
<p>T2 sagittal magnetic resonance imaging (MRI) of the brain showing caudothalamic groove cyst (black arrow). T1 sagittal image of the brain shows hypoplasia of the corpus callosum (white arrow).</p>
</caption>
<graphic xlink:href="10.1177_0883073811435918-fig2.tif"/>
</fig>
<p>DNA methylation studies showed normal biparental inheritance of chromosome 15. High-resolution chromosome study was normal. Array comparative genomic hybridization did not show a genomic imbalance. DNA analysis of Peroxin1 (PEX1) exons 13, 15, 18, and 19 showed a novel mutation involving the last nucleotide of exon 19 (c.3030G&gt;T, p. Glutamine1010Histidine).</p>
<p>Genetic counseling was provided for the family, and the prognosis was shared with them. After this discussion our patient was placed on do-not-resuscitate status and subsequently discharged from the neonatal intensive care unit to a hospice setting at home.</p>
</sec>
<sec id="section2-0883073811435918">
<title>Discussion</title>
<p>Zellweger syndrome was originally described as a lethal, multiple malformation syndrome of infancy.<sup><xref ref-type="bibr" rid="bibr4-0883073811435918">4</xref></sup> The Zellweger spectrum is known to be caused by disorders of peroxisome biogenesis and can be 1 of 3 overlapping phenotypes: Zellweger syndrome (or cerebrohepatorenal syndrome) at the severe end of the spectrum, neonatal adrenoleukodystrophy as an intermediate form, and infantile Refsum disease as a milder form.<sup><xref ref-type="bibr" rid="bibr3-0883073811435918">3</xref></sup> Zellweger syndrome is characterized by neonatal hypotonia, severe neurodevelopmental delay, hepatomegaly, renal cysts, sensorineural deafness, retinal dysfunction, and facial dysmorphism.<sup><xref ref-type="bibr" rid="bibr5-0883073811435918">5</xref></sup> Zellweger syndrome is inherited as an autosomal recessive condition and is caused by mutations in one of a number of Peroxin genes.<sup><xref ref-type="bibr" rid="bibr3-0883073811435918">3</xref></sup>
</p>
<p>Typical Zellweger spectrum patients have dysmorphic faces including a high forehead, broad nasal bridge, epicanthal folds, and micrognathia. They often have large fontanelles and wide sutures at birth. Other features include deformities of the external ear, a high arched palate, shallow orbital ridges, cataracts, corneal clouding, glaucoma, pigmentary retinopathy, optic disc pallor, hepatomegaly, severe hypotonia, seizures, developmental delay, and sensorineural hearing loss.<sup><xref ref-type="bibr" rid="bibr6-0883073811435918">6</xref></sup> Our patient had a constellation of findings including facial dysmorphism, sensorineural deafness, hypotonia, hypoventilation, poor feeding, seizure, elevated liver function tests, defect in peroxisomal fatty acid oxidation, and abnormal findings on brain MRI including polymicrogyria. Polymicrogyria is a malformation of cortical development, occurring near the end of neuronal migration. Heritable causes of polymicrogyria include chromosomal and contiguous-gene disorders such as Deletion 22q11.2 and other developmental abnormalities,<sup><xref ref-type="bibr" rid="bibr7-0883073811435918">7</xref></sup> single gene disorders such as Aicardi syndrome,<sup><xref ref-type="bibr" rid="bibr8-0883073811435918">8</xref></sup> and a number of inborn errors of metabolism including nonketotic hyperglycemia, glutaric academia, and Zellweger syndrome.<sup><xref ref-type="bibr" rid="bibr9-0883073811435918">9</xref></sup>
</p>
<p>The differential diagnoses of a patient with peroxisomal biogenesis disorders include congenital neuromuscular disorders with hypotonia, including Down syndrome, other chromosomal abnormalities, Prader-Willi syndrome, spinal muscular atrophy, congenital myotonic dystrophy type 1, and congenital myopathies such as X-linked myotubular myopathy and multiminicore myopathy,<sup><xref ref-type="bibr" rid="bibr10-0883073811435918">10</xref></sup> Pelizaeus-Merzbacher disease, and chromosomal anomalies. Inborn errors of metabolism should be considered in any patient with neonatal hypotonia.<sup><xref ref-type="bibr" rid="bibr11-0883073811435918">11</xref></sup> Direct involvement of muscle mitochondria in Zellweger syndrome may interfere with energy metabolism and contribute to hypotonia, weakness, and respiratory insufficiency.<sup><xref ref-type="bibr" rid="bibr12-0883073811435918">12</xref></sup>
</p>
<p>Appropriate screening biochemical tests include plasma very long chain fatty acids, which showed elevation in our patient, and red blood cell plasmalogen levels, which were low in our patient and consistent with a defect in plasmalogen metabolism. Given the variability of the peroxisomal biogenesis disorders and the important consequences of this diagnosis for prognosis and counseling, it is reasonable to have a low threshold for screening in patients with features of this class of disorders.<sup><xref ref-type="bibr" rid="bibr13-0883073811435918">13</xref></sup>
</p>
<p>The Peroxin1 (PEX1) mutation found in our patient has not been previously reported, and the clinical significance of this sequence variation is not certain. This nucleotide is the last in exon 19, and this substitution is predicted to affect normal splicing. PolyPhen predicts this substitution to be possibly damaging (PolyPhen-2: http://genetics.bwh.harvard.edu/pph2/), whereas MaxEntScan predicts this change to be tolerated (http://genes.mit.edu/burgelab/maxent/Xmaxentscan_scoreseq.html).</p>
<p>According to Homologene (http://www.ncbi.nlm.nih.gov/homologene), the nucleotide in question is highly conserved across vertebrate species, and polymorphisms seen in invertebrate species are conservative. This information supports the possibility that this mutation is pathological.</p>
<p>Our patient is a product of a consanguineous marriage of second cousins of Native American ethnicity. There are unpublished reports of other cases of Zellweger syndrome in the same tribe. This is likely an example of a “founder effect”<sup><xref ref-type="bibr" rid="bibr14-0883073811435918">14</xref></sup> in that population.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We are thankful to our patient and his family for allowing us to share his story with the medical community.</p>
</ack>
<fn-group>
<fn fn-type="other" id="fn1-0883073811435918"><label>Author Contributions</label>
<p>MM drafted the article. ER, WR, and RB contributed to revising the article. All the authors have been directly involved in the care of this patient. WR and RB provided the support and mentorship necessary for the success of the work as the senior investigators.</p></fn>
<fn fn-type="conflict" id="fn2-0883073811435918"><label>Declaration of Conflicting Interests</label>
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn3-0883073811435918"><label>Funding</label>
<p>The authors received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="other" id="fn4-0883073811435918"><label>Ethical Approval</label>
<p>Informed consent was obtained from the patient’s mother to publish the study.</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0883073811435918">
<label>1.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Gould</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Raymond</surname>
<given-names>GV</given-names>
</name>
<name>
<surname>Valle</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>The peroxisome biogenesis disorders</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Scriver</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Beaudet</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Sly</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>Valle</surname>
<given-names>D</given-names>
</name>
</person-group>, eds. <source>The Metabolic and Molecular Bases of Inherited Disease</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>McGraw-Hill</publisher-name>; <year>2001</year>:<fpage>3181</fpage>–<lpage>3218</lpage>.</citation>
</ref>
<ref id="bibr2-0883073811435918">
<label>2.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Volpe</surname>
<given-names>JJ</given-names>
</name>
</person-group>. <source>Neurology of the Newborn</source>. <publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>WB Saunders</publisher-name>; <year>2001</year>.</citation>
</ref>
<ref id="bibr3-0883073811435918">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weller</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gould</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Valle</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Peroxisome biogenesis disorders</article-title>. <source>Annu Rev Genomics Hum Genet</source>. <year>2003</year>;<volume>4</volume>:<fpage>165</fpage>–<lpage>211</lpage>.</citation>
</ref>
<ref id="bibr4-0883073811435918">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bowen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>CSN</given-names>
</name>
<name>
<surname>Zellweger</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lindenberg</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>A familial syndrome of multiple congenital defects</article-title>. <source>Bull Johns Hopkins Hosp</source>. <year>1964</year>;<volume>114</volume>:<fpage>402</fpage>–<lpage>414</lpage>.</citation>
</ref>
<ref id="bibr5-0883073811435918">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>FitzPatrick</surname>
<given-names>DR</given-names>
</name>
</person-group>. <article-title>Zellweger syndrome and associated phenotypes</article-title>. <source>J Med Genet</source>. <year>1996</year>;<volume>33</volume>:<fpage>863</fpage>–<lpage>868</lpage>.</citation>
</ref>
<ref id="bibr6-0883073811435918">
<label>6.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Raymond</surname>
<given-names>GV</given-names>
</name>
<name>
<surname>Moser</surname>
<given-names>HW</given-names>
</name>
</person-group>. <article-title>Clinical diagnosis and therapy of peroxisomal diseases</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Applegarth</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Dimmick</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>JC</given-names>
</name>
</person-group>, eds. <source>Organelle Diseases</source>. <publisher-loc>London</publisher-loc>: <publisher-name>Chapman &amp; Hall</publisher-name>; <year>1997</year>:<fpage>169</fpage>–<lpage>192</lpage>.</citation>
</ref>
<ref id="bibr7-0883073811435918">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sztriha</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Guerrini</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Harding</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group> <article-title>Clinical, MRI, and pathological features of polymicrogyria in chromosome 22q11 deletion syndrome</article-title>. <source>Am J Med Genet</source>. <year>2004</year>;<volume>127A</volume>:<fpage>313</fpage>–<lpage>317</lpage>.</citation>
</ref>
<ref id="bibr8-0883073811435918">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barkovich</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>CA</given-names>
</name>
</person-group>. <article-title>Callosal agenesis with cyst: a better understanding and new classification</article-title>. <source>Neurology</source>. <year>2001</year>;<volume>56</volume>:<fpage>220</fpage>–<lpage>227</lpage>.</citation>
</ref>
<ref id="bibr9-0883073811435918">
<label>9.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Graf</surname>
<given-names>WD</given-names>
</name>
</person-group>. <article-title>Cerebral dysgeneses secondary to metabolic disorders in fetal life</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Sarnat</surname>
<given-names>HB</given-names>
</name>
<name>
<surname>Curatolo</surname>
<given-names>P</given-names>
</name>
</person-group>, eds. <source>Handbook of Clinical Neurology, Vol. 87: Malformations of the Nervous System</source>. <publisher-loc>Edinburgh, London, New York, NY, Toronto, ON</publisher-loc>: <publisher-name>Elsevier</publisher-name>; <year>2008</year>:<fpage>465</fpage>–<lpage>471</lpage>.</citation>
</ref>
<ref id="bibr10-0883073811435918">
<label>10.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Steinberg</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Raymond</surname>
<given-names>GV</given-names>
</name>
<name>
<surname>Braverman</surname>
<given-names>NE</given-names>
</name>
<name>
<surname>Moser</surname>
<given-names>AB</given-names>
</name>
</person-group>. <article-title>Peroxisome biogenesis disorders, Zellweger syndrome spectrum</article-title>. In: <source>GeneReviews Medical Genetics Information Resource (database online)</source>. <publisher-name>University of Washington</publisher-name>, <publisher-loc>Seattle</publisher-loc>. <year>1997-2011</year>. <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/books/NBK1448/">http://www.ncbi.nlm.nih.gov/books/NBK1448/</ext-link>. <comment>Accessed November 18, 2011</comment>.</citation>
</ref>
<ref id="bibr11-0883073811435918">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baumgartner</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Saudubray</surname>
<given-names>JM</given-names>
</name>
</person-group>. <article-title>Peroxisomal disorders</article-title>. <source>Semin Neonatol</source>. <year>2002</year>;<volume>7</volume>:<fpage>85</fpage>–<lpage>94</lpage>.</citation>
</ref>
<ref id="bibr12-0883073811435918">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarnat</surname>
<given-names>HB</given-names>
</name>
<name>
<surname>Machin</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Darwish</surname>
<given-names>HZ</given-names>
</name>
<name>
<surname>Rubin</surname>
<given-names>SZ</given-names>
</name>
</person-group>. <article-title>Mitochondrial myopathy of cerebro-hepato-renal (Zellweger) syndrome</article-title>. <source>Can J Neurol Sci</source>. <year>1983</year>;<volume>10</volume>:<fpage>170</fpage>–<lpage>177</lpage>.</citation>
</ref>
<ref id="bibr13-0883073811435918">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamaguchi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Iga</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Urinary organic acids in peroxisomal disorders: a simple screening method</article-title>. <source>J Chromatogr</source>. <year>2001</year>;<volume>758</volume>:<fpage>81</fpage>–<lpage>86</lpage>.</citation>
</ref>
<ref id="bibr14-0883073811435918">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Provine</surname>
<given-names>WB</given-names>
</name>
</person-group>. <article-title>Ernst Mayr: genetics and speciation</article-title>. <source>Genetics</source>. <year>2004</year>;<volume>167</volume>:<fpage>1041</fpage>–<lpage>1046</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>